#### Selected Publications 
Miller CL† and Leeper NJ. [GWAS candidate gene to dual modifier of non-alcoholic fatty liver disease and atherosclerosis.][1] Journal of the American College of Cardiology: Basic to Translational Science. 2016.(† corresponding author)   

Knight W, Chen S, Zhang Y, Oikawa M, Wu M, Zhou Q, Miller CL, Cai Y, Mickelsen D, Moravec C, Small EM, Abe JI, Yan C. [PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.][2] Proceedings of the National Academy of Sciences USA. 2016 Oct 20. pii: 201607728. 

Pjanic M, Miller CL, Wirka R, Kim BK, DiRenzo D, Quertermous T. [Genetics and genomics of coronary artery disease.][3] Current Cardiology Reports. 2016. Oct;18(10):102.

Perisic L, Rykaczewska U, Razuvaev A, Sabater-Lleal M, Lengquist M, Miller CL, Eriksson I, Röhl S, Aldi S, Kronqvist M, Gonzalez Diez M, Roy J, Baldassarre D, Veglia F, Humphries SE, de Faire, U, Tremoli E, IMPROVE study group, Odeberg J, Vukojevic V, Paulsson-Berne G, Hansson GK, Lindeman JHN, Eriksson P, Quertermous T, Hamsten A, Hedin U. [Phenotypic modulation of smooth muscle cells in atherosclerosis is associated with downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM.][4] Arteriosclerosis, Thrombosis and Vascular Biology. 2016 Sep;36(9):1947-61. 

Kojima Y‡, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, DiRenzo D, Nanda V, Brady S, Connelly AP, Schadt EE, Quertermous T, Betancur PA, Maegdefessel L, Perisic L, Hedin U, Weissman I, Leeper NJ. [CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis.][5] Nature. 2016 Aug 4;536(7614):86-90. (‡ manuscript received editorial)

[1]: http://www.basictranslational.onlinejacc.org/content/1/7/680
[2]: http://www.pnas.org/content/113/45/E7116.full
[3]: http://link.springer.com/article/10.1007%2Fs11886-016-0777-y
[4]: http://atvb.ahajournals.org/content/early/2016/07/28/ATVBAHA.116.307893
[5]: http://www.nature.com/nature/journal/v536/n7614/full/nature18935.html

#### Additional Publications
